Health outcomes, education, healthcare delivery and quality – 3038: The relation of sTRAIL levels and quality of life in omalizumab using severe persistent allergic asthma patients

Detalles Bibliográficos
Autores principales: Yalcin, Arzu Didem, Bisgin, Atil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2013
Materias:
Meeting Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643273/
http://dx.doi.org/10.1186/1939-4551-6-S1-P212
_version_ 1782268290692808704
author Yalcin, Arzu Didem
Bisgin, Atil
author_facet Yalcin, Arzu Didem
Bisgin, Atil
author_sort Yalcin, Arzu Didem
collection PubMed
description
format Online
Article
Text
id pubmed-3643273
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher World Allergy Organization
record_format MEDLINE/PubMed
spelling pubmed-36432732013-05-08 Health outcomes, education, healthcare delivery and quality – 3038: The relation of sTRAIL levels and quality of life in omalizumab using severe persistent allergic asthma patients Yalcin, Arzu Didem Bisgin, Atil World Allergy Organ J Meeting Abstract World Allergy Organization 2013-04-23 /pmc/articles/PMC3643273/ http://dx.doi.org/10.1186/1939-4551-6-S1-P212 Text en Copyright ©2013 Yalcin and Bisgin; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Abstract
Yalcin, Arzu Didem
Bisgin, Atil
Health outcomes, education, healthcare delivery and quality – 3038: The relation of sTRAIL levels and quality of life in omalizumab using severe persistent allergic asthma patients
title Health outcomes, education, healthcare delivery and quality – 3038: The relation of sTRAIL levels and quality of life in omalizumab using severe persistent allergic asthma patients
title_full Health outcomes, education, healthcare delivery and quality – 3038: The relation of sTRAIL levels and quality of life in omalizumab using severe persistent allergic asthma patients
title_fullStr Health outcomes, education, healthcare delivery and quality – 3038: The relation of sTRAIL levels and quality of life in omalizumab using severe persistent allergic asthma patients
title_full_unstemmed Health outcomes, education, healthcare delivery and quality – 3038: The relation of sTRAIL levels and quality of life in omalizumab using severe persistent allergic asthma patients
title_short Health outcomes, education, healthcare delivery and quality – 3038: The relation of sTRAIL levels and quality of life in omalizumab using severe persistent allergic asthma patients
title_sort health outcomes, education, healthcare delivery and quality – 3038: the relation of strail levels and quality of life in omalizumab using severe persistent allergic asthma patients
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643273/
http://dx.doi.org/10.1186/1939-4551-6-S1-P212
work_keys_str_mv AT yalcinarzudidem healthoutcomeseducationhealthcaredeliveryandquality3038therelationofstraillevelsandqualityoflifeinomalizumabusingseverepersistentallergicasthmapatients
AT bisginatil healthoutcomeseducationhealthcaredeliveryandquality3038therelationofstraillevelsandqualityoflifeinomalizumabusingseverepersistentallergicasthmapatients

Ejemplares similares